Financial insights of ADPT

MyFinsight

For the quarter ending 2025-09-30, ADPT made $93,973,000 in revenue. $9,546,000 in net income. Net profit margin of 10.16%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	93,973,000	58,879,000	52,443,000	44,174,000
Cost of revenue	18,157,000	17,999,000	16,979,000	18,471,000
Research and development	23,669,000	24,134,000	24,203,000	26,263,333.333
Sales and marketing	23,470,000	23,573,000	23,047,000	21,402,666.667
General and administrative	17,959,000	17,786,000	17,399,000	18,516,000
Amortization of intangible assets	428,000	423,000	419,000	425,000
Impairment of long-lived assets	0	-	-	1,801,250
Total operating expenses	83,683,000	83,915,000	82,047,000	87,479,666.667
Income (loss) from operations	10,290,000	-25,036,000	-29,604,000	-43,305,666.667
Interest and other income, net	2,226,000	2,391,000	2,679,000	3,686,666.667
Interest expense	2,971,000	2,948,000	2,905,000	2,880,333.333
Net income (loss)	9,545,000	-25,593,000	-29,830,000	-42,499,333.333
Add net loss (income) attributable to noncontrolling interest	-1,000	21,000	22,000	-25,666.667
Net income (loss) attributable to adaptive biotechnologies corporation	9,546,000	-25,614,000	-29,852,000	-42,473,666.667

Earnings per share, basic	0.06	-0.17	-0.2	-0.287
Earnings per share, diluted, total	0.06	-0.17	-0.2	-0.287
Weighted average number of shares outstanding, basic, total	152,432,307	152,082,284	149,195,028	-138,250
Weighted average number of shares outstanding, diluted, total	163,162,107	152,082,284	149,195,028	-138,250